Dividend History


Forecast Next Dividend Date: Thursday 24 August 2017
Days remaining until next forecast dividend: 120
This is only a forecast. Forecast ex-dividend dates are taken from company's website or by using previous ex-dividend dates as a guide. Please confirm ex-dividend date with your broker.

Dividend Star Rating for HFA HOLDINGS(HFA)

Yield

Reliability

Dividend Growth

Relative Strength

Earnings Growth

Overall

Fundamental Data for HFA HOLDINGS(HFA)

Sector: Diversified Financials
Price: $2.25 (delayed)
Year High: $2.94
Year Low: $1.98
Market Capitalisation: $0.383 billion
Net Tangible Assets: $0.34 billion
Earnings per Share: 0.34 cents
Price Earnings Ratio: 20.1
Forecast Earnings Growth (5 years): 0% per annum
Dividend Cover: 0.73

Dividend Payment History for HFA HOLDINGS(HFA)

Ex-Dividend Date Books Close Date Date Payable Amount Franking Franking Credit Gross Dividend Cum Div Price Gross Yield RoI
22-02-201723-02-201710-03-2017$0.07780%$0.00$0.0778$2.098.09%2.90%
24-08-201625-08-201609-09-2016$0.0912530%$0.00$0.091253$2.506.36%12.26%
01-03-201603-03-201616-03-2016$0.0680%$0.00$0.068$2.306.21%52.88%
01-09-201503-09-201516-09-2015$0.07860%$0.00$0.0786$2.525.51%80.39%
02-03-201504-03-201518-03-2015$0.0640%$0.00$0.064$1.786.60%70.95%
01-09-201403-09-201417-09-2014$0.05380%$0.00$0.0538$1.596.35%128.50%
26-02-201404-03-201427-03-2014$0.0331100%$0.01419$0.04729$1.049.15%26.13%
21-08-201327-08-201306-09-2013$0.03349100%$0.01435$0.04784$0.8210.78%35.58%
26-02-201304-03-201328-03-2013$0.02963100%$0.0127$0.04233$0.919.04%41.76%
23-08-201229-08-201219-09-2012$0.029100%$0.01243$0.04143$0.6919.83%25.28%
27-02-201205-03-201230-03-2012$0.0187100%$0.00801$0.02671$0.7013.71%-79.90%
24-10-201128-10-201125-11-2011$0.0485100%$0.02079$0.06929$0.779.00%-61.50%
08-09-200812-09-200826-09-2008$0.035100%$0.015$0.05$15.180.53%-31.01%
14-03-200820-03-200831-03-2008$0.021100%$0.009$0.03$14.140.62%-44.58%
03-09-200710-09-200728-09-2007$0.04100%$0.01714$0.05714$22.410.52%5.46%
19-03-200723-03-200731-03-2007$0.026100%$0.01114$0.03714$26.100.22%-
10-10-200616-10-200631-10-2006$0.015100%$0.00643$0.02143$19.340.11%-

Notes:

  • Care should be taken interpreting this chart as all dividend payments for final year may not have been paid.
  • The financial year that the dividend is allocated depends on the payment date of the dividend, not the ex-dividend date.
  • Dividend history has not been adjusted for any capital reconstructions which may have effected dividend entitlement per share.

Dividend News Articles for HFA HOLDINGS(HFA)


HFA Holdings Limited (ASX:HFA) Valuation Takes Center Stage - TCT

HFA Holdings Limited (ASX:HFA) Valuation Takes Center Stage
TCT
We also note that HFA Holdings Limited (ASX:HFA) has a Shareholder Yield of 0.075909 and a Shareholder Yield (Mebane Faber) of 0.08841. The first value is calculated by adding the dividend yield to the percentage of repurchased shares. The second ...

and more »


HFA Holdings: It's hard to argue with 10pc a year - The Australian

The Australian

HFA Holdings: It's hard to argue with 10pc a year
The Australian
With a market cap of $324 million, HFA is on the small end of the spectrum, however it has a scalable business model and stable cash flows which support a punchy 10 per cent dividend yield. HFA has flown under the radar in recent years as it recovered ...



HFA Holdings Ltd (HFA.AX) Momentum Rolls On - Business Review

HFA Holdings Ltd (HFA.AX) Momentum Rolls On
Business Review
HFA Holdings Ltd (HFA.AX) has a current ROIC of 7.04. ROIC is calculated by dividing Net Income – Dividends by Total Capital Invested. ROIC measures how effectively company management is using invested capital to generate company income. A high ...

and more »


Should you invest in these 6 fund managers? - Motley Fool Australia

Should you invest in these 6 fund managers?
Motley Fool Australia
Rather than investing your hard earned cash in managed funds and paying huge management fees, investors might want to consider investing in the asset managers themselves. Not all of them are listed of course, and most of Australia's wealth is handled ...



Tesco PLC (TSCO) Shows Continued Strength; Interserve plc (IRV) Less Likely To Cut Dividends - Simply Wall St

Simply Wall St

Tesco PLC (TSCO) Shows Continued Strength; Interserve plc (IRV) Less Likely To Cut Dividends
Simply Wall St
For a few years, shares of the UK's leading retailer were out of favour on account of troubled sales figures. However, over the past year, the company's sales numbers have confirmed that, indeed, a turnaround strategy is in place, as continues ...



Wall St closes at record high (again): ASX to lift-off - Finance News Network

Finance News Network

Wall St closes at record high (again): ASX to lift-off
Finance News Network
The Australian share market will open higher this morning, following strong leads from the US. Wall Street was closed on Monday for its Presidents' Day public holiday. When it re-opened for on Tuesday, it posted new record highs once again, over ...

and more »


23 stocks that doubled or more in the past year - Motley Fool Australia

23 stocks that doubled or more in the past year
Motley Fool Australia
Instead, if you really want to be wealthy, focus on buying quality companies and holding them for the long-term, adding more to your winners over time and letting compounding do its work. To give you a personal example. Since buying shares in Capitol ...



10 value stocks selling at a discount during the crash - Motley Fool Australia

10 value stocks selling at a discount during the crash
Motley Fool Australia
As Charlie Munger once said, “No matter how wonderful a business is, it's not worth an infinite price. We have to have a price that makes sense and gives a margin of safety considering the normal vicissitudes of life.” In keeping with Charlie's ...



Neothetics Announces Last Subject Enrolled in Phase 2 Proof of Concept Trial for LIPO-202 for the Reduction of ... - Nasdaq

Neothetics Announces Last Subject Enrolled in Phase 2 Proof of Concept Trial for LIPO-202 for the Reduction of ...
Nasdaq
LIPO-202 is a proprietary, first-in-class injectable formulation of the well-known long-acting ß2-adrenergic receptor agonist, salmeterol xinafoate, which is an active ingredient of FDA-approved inhaled products such as SEREVENT DISKUS, ADVAIR HFA and ...

and more »


GSK – GlaxoSmithKline plc: Publication of 2016 Annual Financial Report - The Wall Street Transcript

GSK – GlaxoSmithKline plc: Publication of 2016 Annual Financial Report
The Wall Street Transcript
GlaxoSmithKline plc (the 'Company') will today publish on the Company's website, http://annualreport.gsk.com/, its Annual Report for the year ended 31 December 2016 (the '2016 Annual Report').

and more »


Disclaimer
The information provided on this website is for use of a general nature only and is not intended to be relied upon as, nor to be a substitute for, specific professional or investment advice. The team at Dividends.com.au are not lawyers, financial planners, investment advisers, or accountants. So, before taking any action or risking any money, you should always check with your own qualified professional advisers.